Literature DB >> 30556885

MicroRNA-218 prevents lung injury in sepsis by inhibiting RUNX2.

M-H Zhou1, L Zhang, M-J Song, W-J Sun.   

Abstract

OBJECTIVE: To explore the regulatory effects of microRNA-218 on lung tissue of rats with acute lung injury (ALI) and its underlying mechanism.
MATERIALS AND METHODS: A total of 32 Sprague Dawley (SD) rats were randomly divided into control group, lung injury group and microRNA-218 treatment group. The in vitro lung injury model was established by injections of lipopolysaccharide (LPS), PGN (peptidoglycan) and IgG IC (immune complex). Polymerase Chain Reaction (PCR) was performed to detect the expression of microRNA-218 in lung tissues of ALI rats. Enzyme-Linked Immunosorbent Assay (ELISA) was used to measure the level of cytokine secretion in ALI rats. The activity and expression level of nuclear factor-kappa B (NF-κB) in MH-S and RA264.7 cells were determined by Luciferase activity assay and Western blot, respectively.
RESULTS: MicroRNA-218 was significantly down-regulated in bleomycin and IgG IC-induced lung injury rat model, as well as in cells treated with LPS, PGN and IgG IC. Inflammatory factors, including TNF-α, IL-1b, and IL-6, also showed increased in vivo and in vitro expressions. Besides, the overexpression of microRNA-218 inhibited the secretion of inflammatory factors. PCR analysis and Luciferase activity assay indicated that the expressions of RUNX2 and BIRC3 were down-regulated by microRNA-218 in MH-S and RA264.7 cells. Subsequent studies on mechanisms demonstrated that microRNA-218 inhibited the activity of the NF-κB pathway.
CONCLUSIONS: The expression of microRNA-218 markedly decreased in lung tissue of ALI rats, while the expression of inflammatory cytokines showed a remarkable increase, which might be related to the activation of RUNX2 and NF-κB.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30556885     DOI: 10.26355/eurrev_201812_16543

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Tumor necrosis factor-α small interfering RNA alveolar epithelial cell-targeting nanoparticles reduce lung injury in C57BL/6J mice with sepsis.

Authors:  Like Qian; Xi Yin; Jiahao Ji; Zhengli Chen; He Fang; Hu Li; Feng Zhu; Fei Chang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

2.  Current Status of MicroRNAs that Target the Wnt Signaling Pathway in Regulation of Osteogenesis and Bone Metabolism: A Review.

Authors:  Qiang Sun; Siyu Liu; Jingyi Feng; Yue Kang; You Zhou; Shu Guo
Journal:  Med Sci Monit       Date:  2021-04-08

Review 3.  Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review.

Authors:  Aniello Maiese; Andrea Scatena; Andrea Costantino; Enrica Chiti; Carla Occhipinti; Raffaele La Russa; Marco Di Paolo; Emanuela Turillazzi; Paola Frati; Vittorio Fineschi
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

Review 4.  The Pathogenesis of Sepsis and Potential Therapeutic Targets.

Authors:  Min Huang; Shaoli Cai; Jingqian Su
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

Review 5.  Regulatory Role of Non-Coding RNAs on Immune Responses During Sepsis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Normohammad Arefian
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.